Clinical Trials in Boston

Showing 1161-1180 of 17,836 trials

A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

NCT02873962

This research study is evaluating three drugs called Nivolumab, Bevacizumab, and Rucaparib as a possible treatment for relapsed Relapsed Ovarian, Fallopian Tube Or Peritoneal Cancer.

Peritoneal CancerOvarian CancerFallopian Tube Cancer

Dana-Farber Cancer Institute72 participantsStarted Nov 2016

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States

Active Not RecruitingPhase 3< 1 mile

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

NCT05946941

The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.

Sjögren's Syndrome

Bristol-Myers Squibb774 participantsStarted Sep 2023

Fullerton, California, United States • La Palma, California, United States • San Francisco, California, United States +196 more locations

A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

Find Trials by Condition in Boston

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer

Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors

Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes

US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair

Promoting Early Intervention Timing and Attention to Language

Self-discontinuation of Urinary Catheters in a Rural Population

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis

Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2